Learn more

CARDION AG

Overview
  • Total Patents
    24
About

CARDION AG has a total of 24 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Germany. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are CHROMOS MOLECULAR SYSTEMS INC, PROCELLA THERAPEUTICS AB and FUSSENEGGER MARTIN.

Patent filings in countries

World map showing CARDION AGs patent filings in countries

Patent filings per year

Chart showing CARDION AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ruediger Manfred 6
#2 Moll Thomas G 4
#3 Zweigerdt Robert 4
#4 Soria Escoms Bernat 3
#5 Droge Peter 2
#6 Dreher Inge 2
#7 Jones Jonathan 2
#8 Schiller Hilmar 2
#9 Moll Thomas 2
#10 Droege Peter 2

Latest patents

Publication Filing date Title
AU2003293319A1 Expression vectors for selection from stem cells of differentiated cardiomyocytes
DE10261125A1 Preparing stem cells from pancreas, useful as transplants for treating type I diabetes, by converting pancreatic tissue to a suspension and cell selection, applicable to small biopsy samples
DE10259617A1 Treating tissue or cells intended for transplantation, with antimitotic agent to eliminate cells, especially pluri- or multi-potent cells, that are capable of proliferation
DE10257102A1 Preparing high purity cell types from stem cells, useful in drug screening and as transplantation material, by differentiation in an actively aerated bioreactor
EP1271145A1 Methods and cell populations for identifying and validating genomic targets, and for drug screening
EP1370642A2 Pluripotent adult stem cells derived from regenerative tissue
IL156841D0 Pluripotent adult stem cells derived from regenerative tissue
AU2071102A Specific promotor of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof
EP1298201A1 Process for the production of cells exhibiting an islet-beta-cell-like state
DE10109780A1 Episomal vectors containing matrix attachment regions for cell-specific gene expression
AU1823901A Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells
EP1216027A2 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy